Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones.

J Neurooncol

Department of Pharmaceutical Sciences, College of Pharmacy and Biomedical Research Institute, Idaho State University, Pocatello, ID 83209, USA.

Published: September 2006

Glioblastoma multiforme is a primary brain tumor associated with extensive invasion into surrounding brain tissue. Matrix metalloproteinases (MMPs) and urokinase plasminogen activation (uPA) system are shown to be involved in tumor invasion as they help in degradation of extracellular matrix (ECM) proteins and thus assist in the movement of cells. MMP-2 and 9 were shown to be upregulated in gliomas, suggesting their involvement in invasion. Genistein and biochanin A are isoflavones commonly known as phytoestrogens and have some anticancer properties. We hypothesize that these two isoflavones can induce a lowering of tumor invasion by decreasing the activity of matrix degrading enzymes. In this study we investigated the effects of genistein and biochanin A on invasive activity of U87MG cells using the Calbiochem in vitro invasion assay system. Our results suggest that genistein and biochanin A induced a decrease in invasive activity of U87MG cells in a dose-related manner. Genistein also induced a decrease in EGF-stimulated invasion thereby implicating an involvement of EGF-mediated signaling in invasion. Our results also show that treatment of U87MG cells with the two isoflavones induced decreases in the enzymatic activity of MMP-9 and the protein levels of MT1-MMP and uPAR.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-006-9126-0DOI Listing

Publication Analysis

Top Keywords

u87mg cells
16
genistein biochanin
12
matrix degrading
8
degrading enzymes
8
invasion
8
cells isoflavones
8
tumor invasion
8
invasive activity
8
activity u87mg
8
induced decrease
8

Similar Publications

Glioblastoma is considered the most malignant central nervous system tumor. This study aimed to investigate effects of latent transforming growth factor-β binding protein-2 (LTBP2) on glioblastoma growth and associated mechanisms. LTBP2 gene transcription in glioblastoma was determined using RT-PCR.

View Article and Find Full Text PDF

Glioblastoma, with a low survival rate, is an aggressive and difficult-to-treat lethal type of brain cancer. Indomethacin (IND), a non-steroidal anti-inflammatory drug, has antitumoral activity in many cancers, including gliomas. However, its poor aqueous solubility is a critical issue.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates a new cancer treatment system called Chit-IOCO-MTX-Cy5, which combines chitosan nanocomposites with cerium oxide and iron oxide nanoparticles, along with methotrexate and a dye for imaging.
  • The system acts as both an anti-cancer agent and enhances MRI imaging, showing high effectiveness with better results than currently approved imaging agents.
  • It significantly reduces tumor growth with no regrowth after treatment, while showing good safety in mice, indicating its potential as an effective cancer theranostic tool.
View Article and Find Full Text PDF

Background: Glioblastoma multiforme (GBM) is an aggressive brain tumor that primarily affects adults. The Stupp Protocol, which includes surgical resection, chemoradiation, and monotherapy with temozolomide (TMZ), is the standard treatment regimen for GBM. However, repeated use of TMZ leads to resistance in GBM cells, resulting in a poor prognosis for patients.

View Article and Find Full Text PDF

Arachidonoylethanolamide promotes cellular senescence in a human glioblastoma cell line.

Biochem Biophys Res Commun

January 2025

Laboratorio de Neuroquímica, Facultad de Medicina, Universidad Autónoma Del Estado de México, Paseo Tollocan esq, Jesús Carranza s/n, Col. Moderna de la Cruz, Toluca, Mexico, CP 50180. Electronic address:

Glioblastomas are the most common and deadly primary brain tumors, with high mortality rates despite aggressive therapies. Cellular senescence is important for cancer development, as it limits tumor progression; however, it may also stimulate inflammation at the tumor microenvironment, promoting tumor development. Hence, modulation of senescence is an important target for cancer therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!